NTRK2 and astrocytoma (excluding glioblastoma): For instance, increased TrkB expression was detected in low-grade astrocytoma and GBM [287,288], while BDNF-induced activation of TrkB was found to increase the viability of tumor-initiating cells isolated from GBM [146].